Does endometrial receptivity testing treat implantation failure?

Endometrial receptivity testing does not directly treat implantation failure; it assesses the uterine lining. The test uses a sample taken at a planned point in a treatment cycle to look for signals associated with the lining's readiness for embryo transfer. Results may be used to discuss timing, but the test does not repair the lining or ensure implantation.

Implantation failure can have several contributing factors, including embryo characteristics, uterine anatomy, lining development, hormonal timing, and medical conditions. Receptivity testing focuses on one part of that picture. A result may not explain every failed transfer, and the meaning of the result depends on the fertility plan, the sampling method, and the clinician's interpretation.

Ask the fertility team what question the test is intended to answer and how its result would change your next transfer plan. Discuss the timing of the biopsy, discomfort, bleeding, infection precautions, and any delay to treatment. Review other assessments that may be relevant, such as uterine imaging, hormone review, or evaluation of embryo-related factors. Make sure you understand what will happen if the result is inconclusive.

After sampling, contact the clinic for heavy bleeding, severe or worsening pelvic pain, fever, faintness, or unusual-smelling discharge. Before testing, seek advice if you may be pregnant, have an active pelvic infection, or take medicines that affect bleeding. Follow the clinic's specific preparation and aftercare instructions.

What will this test measure in my situation? How could the result change embryo-transfer timing? What alternatives or complementary assessments should we consider? What are the biopsy risks and recovery expectations?